Malignant Pleural Mesothelioma: A Unique Challenge

Cancer is a formidable foe, but the battle takes on an even heavier tone when it comes to malignant pleural mesothelioma (MPM), which develops in the lining of the lungs. This rare and aggressive form of cancer, primarily linked to asbestos exposure, presents a unique set of challenges.

Dr. Barry C. Gibney of the Medical University of South Carolina and Dr. Frank C. Detterbeck of Yale University are leading experts in thoracic oncology. They provided a peer review of a recent study examining survival for different cell types and the role of surgery in the treatment of pleural mesothelioma.

Their insights could potentially reshape the way we approach this devastating disease and offer a beacon of hope for those affected by mesothelioma of the pleura.

The Cell Types of Pleural Mesothelioma

A key question has been whether surgery is beneficial for all forms of pleural mesothelioma, which is categorized into three cell subtypes:

The complexity of this disease makes it difficult to pinpoint the best treatment approach. Current guidelines recommend a combination of therapies including:

However, the ideal combination of treatments and their sequence remains unclear.

The Research Study and Its Findings

The recent research study, published in the May 2023 edition of CHEST® Journal, aimed to shed some light on this question. Researchers analyzed data from the National Cancer Database spanning 2004 to 2017, focusing on early-stage MPM patients.

The results were intriguing. Surgery seemed to offer clear benefits for patients with the epithelioid subtype of MPM compared to chemotherapy alone. However, the benefits were less clear for the biphasic and sarcomatoid subtypes.

Nevertheless, the study had its limitations. For one, the use of retrospectively collected data from the National Cancer Database can introduce confounding factors that make it challenging to draw definitive conclusions. Moreover, the study didn’t account for important factors like patients’ overall health status, the success of the surgery in removing all visible cancer, socioeconomic factors, and the severity of other health conditions the patients had.

The Future of Malignant Pleural Mesothelioma Treatment: Immunotherapy and Beyond

Furthermore, the study period predates the use of immunotherapy, a newer form of cancer treatment that activates the body’s immune system to fight the disease. Also on the horizon are targeted therapies, such as mesothelin-targeted chimeric antigen receptor (CAR) T-cell therapies, which are currently being tested in clinical trials and are showing great promise.

The Shift in the Role of Surgery in Pleural Mesothelioma Treatment

The study’s findings reinforce the case for surgery in treating epithelioid pleural mesothelioma. The benefits for the biphasic and sarcomatoid subtypes are less clear, and more research is needed. However, with the emergence of immunotherapy and other personalized therapies, the role of surgery in treating MPM is shifting.

The Importance of a Team Approach

This underlines the importance of treating MPM as a “team sport.” The best outcomes for patients are likely to be achieved when a team of medical professionals, each with their own expertise, come together to provide individualized therapy.

This approach maximizes the chances of survival and provides the best quality of life for individuals battling this formidable disease. As we continue to learn more about pleural mesothelioma, develop new treatments, and refine our existing approach, there is growing hope for those affected by this devastating cancer.

Key Takeaways

  1. MPM is a complex disease, and treatment often involves a combination of therapies.
  2. Surgery shows clear benefits for patients with the epithelioid subtype of pleural mesothelioma, but benefits for other subtypes are unclear.
  3. New treatments such as immunotherapy and targeted therapies are changing the landscape of MPM treatment.
  4. An integrated surgical team approach is vital for providing the best individualized care and improving patient outcomes and life expectancy.

Diagnosed and Looking for a Specialist?

Use our Free Doctor Match program and get connected with a mesothelioma specialist near you.

Mesothelioma Guide Images
Get Your Free 2024 Mesothelioma Guide
  • Symptoms & staging
  • Average prognosis
  • Life-extending treatments

Get Your Free Guide

Laura WrightWritten by:

Lead Editor

Laura Wright is a journalist and content strategist with more than 15 years of professional experience. She attended college at the University of Florida, graduating magna cum laude with a bachelor’s degree in journalism in 2008. Her writing has been featured in The Gainesville Sun and other regional publications throughout Florida.

Our Promise to You
Our Promise to You
  1. Mansur, A., et al. (May 2023). An Investigation of Cancer-Directed Surgery for Different Histologic Subtypes of Malignant Pleural Mesothelioma. Chest, 163(5), 1292–1303. Retrieved May 11, 2023, from 

  2. Gibney, B. C., & Detterbeck, F. C. (May 2023). Cancer-Directed Surgery for Mesothelioma: A Team Sport. In Chest (Vol. 163, Issue 5, pp. 1018–1019). Elsevier BV. Retrieved May 10, 2023, from

Get Your Free 2024 Mesothelioma Guide

  • Symptoms & staging
  • Average prognosis
  • Life-extending treatments
Get Your Free Guide Now
Mesothelioma guide